July 2025 Letter from METAvivor’s President
July 22, 2025
BY Kelly Shanahan, M.D. METAVivor President and Director of Research I hope everyone is enjoying their summer. We are busy gearing up for the relaunch
Explore updates on metastatic breast cancer research, hear from the MBC community, and learn how your support is making a difference.
BY Kelly Shanahan, M.D. METAVivor President and Director of Research I hope everyone is enjoying their summer. We are busy gearing up for the relaunch
BY Kelly Shanahan, M.D. METAvivor President and Director of Research Those researchers invited to submit a full application are hard at work – applications are
BY METAvivor Advocacy Team Dear METAvivor Advocates, Greetings from your METAvivor Advocacy team! This month, we’ve continued our strong advocacy on your behalf, monitoring key
BY Alpha Lilstrom Cheng, METAvivor Board Vice President Submitted by: Alpha Lillstrom Cheng, Board Vice President, METAvivor Prepared For: Subcommittee on Labor, Health and Human Services, Education,
BY Kelly Shanahan, M.D. METAvivor President and Director of Research There is so much work going on behind the scenes at METAvivor. I’ve been putting
BY METAvivor Advocacy Team Dear METAvivor Advocates, Greetings from your METAvivor Advocacy team! This month, we’ve engaged in numerous advocacy efforts on your behalf,
BY Janice Cowden Director of Peer-to-Peer At METAvivor, we believe in the power of peer connection—especially for those living with metastatic breast cancer (MBC). That’s
BY Kelly Shanahan, M.D. “As a mom, as a doctor, and now as an advocate for and a person living with metastatic breast cancer, I’ve
BY Kelly Shanahan, M.D. METAvivor President and Director of Research Phew, it’s been a crazy start to 2025 but we’ve hit the ground running
BY Kelly Shanahan, M.D. METAvivor President and Director of Research METAvivor’s core mission is to fund research that will benefit those of us whose cancer
We’re thrilled to share exciting news from METAvivor: we have received 195 Letters of Intent (LOIs) for our 2025 metastatic breast cancer (MBC) research grant cycle — nearly double
BY Gloria Echeverria, PhD Feb 25, 2025 Note: These views are my own and do not necessarily represent those of my current employer, Baylor College
